Picture of Bio Path Holdings logo

BPTH — Bio Path Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Bio Path Holdings Inc expected to post a loss of 33 cents a share - Earnings Preview

* Bio Path Holdings Inc  BPTH.OQ   BPTH.O  is expected to show
no change in quarterly revenue when it reports  results on
November 12. 
​* Refinitiv's mean analyst estimate for Bio Path Holdings Inc
is for a loss of 33 cents per share. For the same quarter last
year, the company reported a loss of 80 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Bio Path
Holdings Inc is $12.5​, about 61.4% above​ its last closing
price of $4.82. ​​​
This summary was machine generated November 10 at 11:10 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on Bio Path Holdings

See all news